Radboud University Medical Center: clinical-trial pipeline
Radboud University Medical Center is the sponsor of 984 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 126 are not yet finished and 5 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 652 |
| Phase 4 | 98 |
| Phase 2 | 84 |
| Phase 1 | 50 |
| Phase 3 | 38 |
| Phase 1/2 | 36 |
| Phase 2/3 | 19 |
| Early phase 1 | 7 |
Trials by status
| Status | Trials |
|---|---|
| Completed | 562 |
| Unknown | 228 |
| Recruiting | 70 |
| Terminated | 58 |
| Active, not recruiting | 28 |
| Not yet recruiting | 28 |
| Withdrawn or not authorised | 7 |
| Suspended or halted | 3 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 255 |
| Infectious disease and vaccines | 153 |
| Cardiovascular | 112 |
| Nephrology and urology | 78 |
| Rare and genetic diseases | 76 |
| Metabolic and endocrine (diabetes, obesity) | 73 |
| Neurology | 73 |
| Gastroenterology and liver | 70 |
| Immunology and rheumatology | 46 |
| Respiratory | 42 |
| Psychiatry and mental health | 31 |
| Women's health and obstetrics | 30 |
Countries
| Country | Trials |
|---|---|
| Netherlands | 897 |
| Germany | 21 |
| Belgium | 17 |
| United Kingdom | 13 |
| Italy | 10 |
| Spain | 8 |
| United States | 7 |
| Denmark | 6 |
| France | 6 |
| Tanzania | 6 |
| Greece | 5 |
| Austria | 4 |
| Sweden | 4 |
| Switzerland | 3 |
| Canada | 2 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-10-16 | New trial posted | Screening and the Future of Enhanced MRI for Early Breast Cancer Detection |
| 2026-09-15 | New trial posted | Affordable, Tailored Therapy for Financially Vulnerable People With Trauma-related Injuri… |
| 2026-09-15 | New trial posted | Diaphragm Hibernation and Its Driving Factors in Mechanically Ventilated ICU Patients |
| 2026-09-03 | New trial posted | Brachytherapy (Interventional Radiotherapy) for Squamous Cell Carcinomas of the Nasal Ves… |
| 2026-08-31 | New trial posted | Affordable, Tailored Physical Therapy for Financially Vulnerable People With Trauma-relat… |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT05865743 | Perioperative SDD to Prevent Infectious Complications After Esophagectomy | Phase 3 | Recruiting | Belgium, Netherlands |
| NCT04909684 | Dose Tapering and Early Discontinuation to InCreAse cosT-effectIveness Of Immunotherapy for NSCLC | Phase 3 | Active, not recruiting | Netherlands |
| NCT05418907 | Exendin PET/CT for Imaging of Paragangliomas | Not applicable | Recruiting | Netherlands |
| NCT05078671 | Pharmacokinetic Boosting of Olaparib to Improve Exposure, Tolerance and Cost-effectiveness | Phase 4 | Recruiting | Netherlands |
| NCT04834388 | Studying Anakinra to Reduce Secondary Brain Damage After Spontaneous Haemorrhagic Stroke | Phase 2 | Recruiting | Netherlands |
| NCT06411028 | Factors Determining the Efficacy of Botulinum Toxin for Arm Tremor in Dystonia | Phase 4 | Active, not recruiting | Netherlands |
| NCT03182296 | Visualizing Beta Cells in Patients With a History of Gestational Diabetes | Not applicable | Not yet recruiting | Netherlands |
| NCT02875262 | Deferoxamine in Aneurysmal Subarachnoid Hemorrhage Trial | Phase 1/2 | Recruiting | Netherlands |
| NCT05477459 | LSD to Improve Cluster Headache Impact Trial | Phase 2 | Recruiting | Netherlands |
| NCT05633576 | Steroid Eye Drops in Chronic Central Serous Chorioretinopathy | Phase 3 | Recruiting | Netherlands |
| NCT04615910 | A GLP-1 Receptor PET Imaging Substudy Within the VER-A-T1D Trial Investigating the Effects on Beta Cell Mass | Phase 2 | Not yet recruiting | Austria, France |
| NCT07105202 | Shorter Weaning From Invasive Ventilation With Levosimendan | Phase 4 | Recruiting | Netherlands |
| NCT07163611 | Obinutuzumab Induced Decreases of PLA2R Antibodies in Membranous Nephropathy: a Pilot Study | Phase 2/3 | Recruiting | Netherlands |
| NCT07009184 | TGW211 for Click-Cleavable Imaging in HER2-Positive Cancers. | Early phase 1 | Recruiting | Netherlands |
| NCT07530263 | Deposition of Inhaled Liposomal Amphotericin B in Chronic Pulmonary Aspergillosis (CPA) | Phase 1 | Not yet recruiting | Netherlands |
| NCT07582458 | Modafinil for Debilitating Fatigue in Quiescent Inflammatory Bowel Disease MODIFI-IBD Trial) | Phase 2/3 | Recruiting | Netherlands |
| NCT07485569 | Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial | Phase 1 | Active, not recruiting | Netherlands |
| NCT07412197 | Preventive Dendritic Cell Vaccination for Lynch Syndrome | Phase 1/2 | Not yet recruiting | Netherlands |
| NCT05413616 | The Effect of a Combined Personalized Nutritional Intervention and a Personalized Graded Activity Functional… | Not applicable | Recruiting | Netherlands |
| NCT07203781 | PEEP-induced Effects on Respiratory dRivE and EFfort | Not applicable | Recruiting | Netherlands |
| NCT06083155 | The NetherLands Registry of Invasive Coronary Vasomotor Function Testing (NL-CFT) | Not applicable | Recruiting | Netherlands |
| NCT06227182 | Magnetic Resonance Imaging and Ultrasound Comparison With Load Evaluation | Not applicable | Recruiting | Netherlands |
| NCT07696715 | Timing of Immunotherapy in Melanoma | Not applicable | Recruiting | Netherlands |
| NCT06259136 | Palliative Care Yields Cancer Wellbeing Support | Not applicable | Recruiting | Netherlands |
| NCT02383342 | Pain Predict Genetics | Not applicable | Active, not recruiting | Netherlands |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Radboud University Medical Center clinical trials: 126 open, 57 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/radboud-university-medical-center/, data as of 2026-10-25.